Debate Over the Legal Status of DayQuil Intensifies

The piece examines the controversy surrounding DayQuil, an over‑the‑counter cold medicine. It outlines concerns about misuse and potential for abuse. Proponents argue the drug provides essential relief and should remain accessible. Opponents cite reports of high‑dose consumption and health risks. The article reviews existing regulations on its active ingredients. It discusses possible policy changes, including age restrictions. It references expert opinions from pharmacists and public‑health officials. It concludes by weighing public safety against consumer convenience.